The World’s First Crispr Drug Gets a Slow Start
2 weeks, 4 days ago

The World’s First Crispr Drug Gets a Slow Start

Wired  

Deshawn “DJ” Chow waited a year to receive a treatment that could change his life. It’s the first approved medicine to use the Nobel Prize–winning technology known as Crispr, a type of gene editing. Another genetic treatment for sickle cell, Lyfgenia, won approval last December, and the first patient was treated in September. Chow is City of Hope’s first sickle cell patient, while a beta thalassemia patient has been treated at Children’s National. “The process of getting this drug is very different from just taking a pill,” says Leo Wang, Chow’s hematologist-oncologist at City of Hope.

History of this topic

The First Crispr Treatment Is Making Its Way to Patients
1 month, 3 weeks ago
Gene Editing Needs to Be for Everyone
1 year ago
The Age of Crispr Medicine Is Here
55 years ago
Game-changer: The Hindu Editorial on approval for gene therapy to treat sickle cell disease and beta thalassemia
1 year ago
The First Crispr Medicine Is Now Approved in the US
55 years ago
FDA approves 2 gene therapies for sickle cell. One is the first to use the editing tool CRISPR
1 year, 1 month ago
Gene therapy offers new hope for sickle cell disease cure
1 year, 1 month ago
UK becomes 1st country to approve gene therapy treatment for sickle cell, thalassemia
1 year, 1 month ago
A new cure for sickle cell disease may be coming. Health advisers will review it next week
1 year, 2 months ago
A Gene Therapy Cure for Sickle Cell Is on the Horizon
1 year, 9 months ago
Gene-editing treatment shows promise for sickle cell disease
4 years, 1 month ago
Doctors In The U.S. Use CRISPR Technique To Treat A Genetic Disorder For The 1st Time
5 years, 5 months ago
In A 1st, Doctors In U.S. Use CRISPR Tool To Treat Patient With Genetic Disorder
5 years, 5 months ago

Discover Related